Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
amgen
boston blog main
clinical trials
inclisiran
new york blog main
new york top stories
regeneron pharmaceuticals
biotech
boston top stories
cholesterol
national top stories
new york
alirocumab
alnylam pharmaceuticals
evolocumab
pcsk9
pcsk9 inhibitors
praluent
repatha
sanofi
study
archive
detroit blog main
detroit top stories
fda
heart attack
ldl
medical
medicines co.
mt sinai hospital
prashant vaishnava
research
rna interference
san francisco blog main
san francisco top stories
statins
stroke
the medicines co.
What
cholesterol
9
×
drug
9
×
lowering
medicines
new
fda
medco
wave
drugs
heart
ldl
levels
published
twice
aces
acquire
additional
administration
advisory
agreed
alnylam
announced
approval
approved
approving
attacks
bacteria
bad
based
big
billion
bringing
brings
cardiovascular
cash
casts
ceo
changes
clear
clears
Language
unset
Current search:
cholesterol
×
drug
×
@slashgear.com
2 years ago
Johns Hopkins study casts doubt on statins as COVID-19 treatment
@slashgear.com
3 years ago
Common cholesterol drugs may trigger protective gut bacteria changes
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@theverge.com
8 years ago
FDA panel recommends approving new drug that dramatically lowers cholesterol